Traynor Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Traynor Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,548	Closed	-$622K	–	178
2019 Q3	$622K	Sell	10,548 -880	-8%	-$56.2K	0.19%	89
2019 Q2	$745K	Hold	11,428	–	–	0.24%	73
2019 Q1	$725K	Buy	+11,428	New	+$600K	0.24%	70
2018 Q4	–	Sell	-33,423	Closed	-$1.43M	–	190
2018 Q3	$1.43M	Buy	33,423 +413	+1%	+$14.4K	0.46%	42
2018 Q2	$706K	Buy	+33,010	New	+$406K	0.26%	70

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Traynor Capital Management's TNDM Position: Q4 2019 in Review

Traynor Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2019, closing a stake of 10,548 shares — an estimated $622K sold.

Traynor Capital Management first reported a position in TNDM in Q2 2018 and held it in 5 quarters. The position peaked at $1.43M in Q3 2018. 284 funds tracked by Wall St. Rank hold TNDM as of Q4 2019.

Traynor Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2019 after selling out during the quarter.
Traynor Capital Management sold 10,548 Tandem Diabetes Care shares in Q4 2019, an estimated $622K.
Traynor Capital Management first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 5 quarters.
Traynor Capital Management's Tandem Diabetes Care position peaked at $1.43M in Q3 2018.
284 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2019.

Based on Traynor Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.